Award

Consultant (National Clinical Lead) for Phase 2 of the ATTC Programme

  • CELL THERAPY CATAPULT LIMITED

UK5: Transparency notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2025/S 000-055243

Procurement identifier (OCID): ocds-h6vhtk-05973d

Published 10 September 2025, 9:54am



Scope

Description

To make a direct award to 'Kings College London', to deliver, using an experienced consultant to be the National Clinical Lead for the Advanced Therapy Treatment Centres in relation to supporting with NHS preparedness and clinical trials for ATMPs.


Contract 1

Supplier

Contract value

  • £29,308.86 including VAT

Below the relevant threshold

Earliest date the contract will be signed

15 September 2025

Contract dates (estimated)

  • 16 September 2025 to 17 September 2026
  • 1 year, 2 days

Main procurement category

Services

CPV classifications

  • 73210000 - Research consultancy services

Contract locations

  • UK - United Kingdom

Procedure

Procedure type

Below threshold - without competition


Supplier

KING'S COLLEGE LONDON

  • Companies House: RC000297
  • Public Procurement Organisation Number: PHYJ-5565-GJZD

120 The Strand

London

WC2R 2LS

United Kingdom

Region: UKI32 - Westminster

Small or medium-sized enterprise (SME): No

Voluntary, community or social enterprise (VCSE): No

Contract 1


Contracting authority

CELL THERAPY CATAPULT LIMITED

  • Companies House: 07964711
  • Public Procurement Organisation Number: PNLN-8116-PBCH

12th Floor Tower Wing B

London

SE1 9RT

United Kingdom

Region: UKI44 - Lewisham and Southwark

Organisation type: Public authority - sub-central government